Group Pushes Bill To Increase Female Representation In Device Clinical Trials
This article was originally published in The Gray Sheet
Executive Summary
The National Coalition for Women with Heart Disease is pressing lawmakers to pass a bill that would encourage more equal representation of women in clinical trials for cardiovascular devices.
You may also be interested in...
Study Finds Heart Device Trials Male-Dominated; FDA Promises Guidance
Women remain underrepresented in pivotal studies of cardiac devices submitted to FDA, and there is a lack of analysis distinguishing between trial outcomes in men and women, researchers conclude in a study published online March 1.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.